Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
1. To evaluate the dose response of JNJ-54781532 at Week 8 in subjects with moderately to severely active UC. 2. To evaluate the safety of JNJ-54781532 in subjects with moderately to severely active UC.
Critère d'inclusion
- Ulcerative colitis